Aster Capital Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.62K Buy
+100
New +$4.58K ﹤0.01% 854
2026
Q2
– Sell
-571
Closed -$34.5K – 915
2026
Q1
$34.5K Sell
571
-152
-21% -$6.18K 0.01% 491
2025
Q4
$29.4K Buy
723
+581
+409% +$25.3K 0.01% 550
2025
Q3
$6.68K Sell
142
-788
-85% -$40.9K ﹤0.01% 786
2025
Q2
$48.4K Sell
930
-25
-3% -$1.37K 0.01% 609
2025
Q1
$56.5K Buy
955
+901
+1,669% +$58.1K 0.01% 789
2024
Q4
$3.7K Buy
+54
New +$3.76K ﹤0.01% 899

Other funds holding CNMD

Aster Capital Management's CNMD Position: Q3 2026 in Review

Aster Capital Management opened a new position in CONMED (CNMD) in Q3 2026: 100 shares worth $4.62K. The stake represents ﹤0.01% of the portfolio and ranks #854 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in CNMD as recently as Q1 2026.

Aster Capital Management first reported a position in CNMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $56.5K in Q1 2025. 270 funds tracked by Wall St. Rank hold CNMD as of Q3 2026.

  • Aster Capital Management held 100 shares of CONMED worth $4.62K as of Q3 2026.
  • CONMED was a new Aster Capital Management position in Q3 2026.
  • CONMED made up ﹤0.01% of Aster Capital Management's portfolio in Q3 2026, its #854 holding.
  • Aster Capital Management first reported a position in CONMED in Q4 2024 and has held it in 7 quarters since.
  • Aster Capital Management's CONMED position peaked at $56.5K in Q1 2025.
  • 270 funds tracked by Wall St. Rank held CONMED as of Q3 2026.

Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.